Home › Funds › Values First Advisors, Inc. › EBS

Values First Advisors, Inc. position in EBS

EMERGENT BIOSOLUTIONS INC · Health Care

Values First Advisors, Inc. reported holding 296,098 shares of EBS (EMERGENT BIOSOLUTIONS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.92% of its reported portfolio and ranking #32 among its reported holdings. Values First Advisors, Inc. has disclosed EBS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)296.10K sh
Reported value held$1.95M
Portfolio Weight0.92%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Values First Advisors, Inc.'s EBS position evolved

Values First Advisors, Inc. first disclosed a stake in EBS in Q3 2023 at 152,699 shares (US$519K). The position peaked in Q3 2024 at 456,208 shares, worth US$3.8M. Across 13 filings, Values First Advisors, Inc. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 296,098 shares valued at US$2.0M — a reduction of -5,390 shares quarter over quarter.. Notable position changes include a 102% increase in Q4 2023 (shares rose 5% over the following quarter), a 53% increase in Q1 2024 (shares rose 170% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 152.70K $519.18K New
Q4 2023 307.89K $738.94K Add
Q1 2024 470.09K $1.19M Add
Q2 2024 466.15K $3.18M Reduce
Q3 2024 456.21K $3.81M Reduce
Q4 2024 376.69K $3.60M Reduce
Q1 2025 375.25K $1.81M Hold
Q2 2025 376.00K $2.40M Hold
Q3 2025 367.92K $3.25M Reduce
Q4 2025 305.05K $3.77M Reduce
Q1 2026 307.88K $2.56M Add
Q2 2026 301.49K $2.53M Reduce
Q3 2026 296.10K $1.95M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EBS and 13F data

EBS (EMERGENT BIOSOLUTIONS INC) is a Health Care company. 24 other funds we track also report a position in EBS — the largest reported positions include OAK HILL ADVISORS LP (US$9.3M), PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (US$7.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EBS

All EBS fund holders →

FAQ

How long has Values First Advisors, Inc. held EBS?

Values First Advisors, Inc. has disclosed EBS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Values First Advisors, Inc.'s current position in EBS?

As of Q3 2026, Values First Advisors, Inc. holds 296.10K shares of EBS (EMERGENT BIOSOLUTIONS INC), valued at $1.95M, representing 0.92% of its reported portfolio and ranking #32.

Has Values First Advisors, Inc. been buying or selling EBS?

In the latest 13F filing (Q3 2026), Values First Advisors, Inc. reduced its position in EBS. The position peaked in Q3 2024 at 456.21K shares.

Which other funds hold EBS?

Other major institutional holders of EBS include OAK HILL ADVISORS LP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.